Skip to main content
DNLI logo

DNLI · Denali Therapeutics Inc. · Holdings

Track DNLI — free
$19.45 +0.78 (+4.18%) At close · Oct 9
Market Cap
$3.08B
Shares
159.85M
Volume · Oct 9 1.34M Avg daily vol (3M) 1.62M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Institutional holdings are being reconciled with SEC filings. Holder totals and changes may be incomplete until reconciliation finishes.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 296
Total Value: $4,047,530,081
Total Shares: 157,432,702
Showing 1–100 of 301 holdings by value · page 1 of 4

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 297 13F filers
Top Holder
10.3%
Sep 2023 → Jun 2026 · range 8.6% – 13.5%
of institutional value
Top 5
35.7%
Sep 2023 → Jun 2026 · range 31.6% – 46.2%
of institutional value
Top 10
51.9%
Sep 2023 → Jun 2026 · range 49.0% – 65.1%
of institutional value
HHI
396
Sep 2023 → Jun 2026 · range 340 – 560
Broadly held
Showing 100 of 301
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1714899 CUSIP 24823R105 13F (30d) 7 filings 7 filers Visit website Investor relations